Valeant May Have 'Paid Too Much' for Its So-Called 'Crown Jewel' Assets

Valeant, whose shares are down more than 92 percent since their highs last summer, have been pressured by a roughly $31 billion debt stack.
Author:
Publish date:

Valeant (VRX) , whose shares are down more than 92 percent since their highs last summer, have been pressured by a roughly $31 billion debt stack, but new management at the helm has been trying to reassure investors that the company can unwind debt through asset sales. But Wells Fargo Securities (WFC) - Get Report analyst David Maris said in a report Wednesday that one of Valeant's chief assets, eye care giant Bausch & Lomb, is now worth less than when Valeant bought it for $8.7 billion in 2013.

This article was written by a staff member of TheStreet.